Annual report pursuant to Section 13 and 15(d)

Segment Information (Tables)

v3.20.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of segment reporting information

    Years Ended
December 31,
 
    2019     2018  
Revenues            
Real property operations   $ 1,155,677     $ 1,121,483  
Medical related consulting services – related parties     355,544       269,287  
Development services and sales of developed products     35,084       171,516  
Total     1,546,305       1,562,286  
                 
Costs and expenses                
Real property operations     818,662       793,714  
Medical related consulting services – related parties     284,472       250,320  
Development services and sales of developed products     103,258       130,238  
Total     1,206,392       1,174,272  
                 
Real property operating income     337,015       327,769  
Gross profit from medical related consulting services     71,072       18,967  
Gross (loss) profit from development services and sales of developed products     (68,174 )     41,278  
                 
Other operating expenses                
Real property operations     325,637       245,472  
Medical related consulting services     628,625       356,294  
Development services and sales of developed products     1,652,840       786,278  
Corporate/Other     17,110,041       6,631,105  
Total     19,717,143       8,019,149  
                 
Other income (expense)                
    Interest expense                
                 
Real property operations     (32,877 )     (312,329 )
Corporate/Other     (50,031 )     (2,324 )
Total     (82,908 )     (314,653 )
                 
Other                
Real property operations     2,182       10  
Medical related consulting services – related parties     (40,459 )     (49,154 )
Development services and sales of developed products     (1,369 )     49,565  
Corporate/Other     1,429,623       (106,929 )
Total     1,389,977       (106,508 )
Total other income (expense)     1,307,069       (421,161 )
                 
Net loss                
Real property operations     19,317       230,022  
Medical related consulting services     598,012       386,481  
Development services and sales of developed products     1,722,383       695,435  
Corporate/Other     15,730,449       6,740,358  
    $ 18,070,161     $ 8,052,296  

 

Identifiable long-lived tangible assets at December 31, 2019 and 2018   December 31,
2019
    December 31,
2018
 
Real property operations   $ 7,750,743     $ 7,898,224  
Medical related consulting services     263,621       6,852  
Development services and sales of developed products     322,741       224,364  
    $ 8,337,105     $ 8,129,440  

 

Identifiable long-lived tangible assets at December 31, 2019 and 2018   December 31,
2019
    December 31,
2018
 
United States   $ 7,839,093     $ 7,898,806  
China     498,012       230,634  
    $ 8,337,105     $ 8,129,440